rs7336610

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The ENST00000581816.2(MIR17HG):​n.3074C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.472 in 151,662 control chromosomes in the GnomAD database, including 18,387 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.47 ( 18387 hom., cov: 29)

Consequence

MIR17HG
ENST00000581816.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.480

Publications

21 publications found
Variant links:
Genes affected
MIR17HG (HGNC:23564): (miR-17-92a-1 cluster host gene) This gene is the host gene for the MIR17-92 cluster, a group of at least six microRNAs (miRNAs) that may be involved in cell survival, proliferation, differentiation, and angiogenesis. Amplification of this gene has been found in several lymphomas and solid tumors. Two non-protein coding transcript variants have been found for this host gene, but only the longest is a polycistronic transcript containing the MIR17-92 cluster. [provided by RefSeq, May 2012]
MIR17HG Gene-Disease associations (from GenCC):
  • Feingold syndrome type 2
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 13-91352883-C-T is Benign according to our data. Variant chr13-91352883-C-T is described in ClinVar as Benign. ClinVar VariationId is 3060743.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.577 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR17HGNR_027350.2 linkn.3459C>T non_coding_transcript_exon_variant Exon 2 of 2
MIR17HGNR_197388.1 linkn.3074C>T non_coding_transcript_exon_variant Exon 3 of 3
MIR17HGNR_027349.2 linkn.418-1050C>T intron_variant Intron 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MIR17HGENST00000581816.2 linkn.3074C>T non_coding_transcript_exon_variant Exon 3 of 3 1
MIR17HGENST00000582141.7 linkn.3459C>T non_coding_transcript_exon_variant Exon 2 of 2 1
MIR17HGENST00000400282.8 linkn.285-1050C>T intron_variant Intron 3 of 3 1

Frequencies

GnomAD3 genomes
AF:
0.472
AC:
71506
AN:
151546
Hom.:
18375
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.259
Gnomad AMI
AF:
0.637
Gnomad AMR
AF:
0.587
Gnomad ASJ
AF:
0.525
Gnomad EAS
AF:
0.501
Gnomad SAS
AF:
0.586
Gnomad FIN
AF:
0.448
Gnomad MID
AF:
0.541
Gnomad NFE
AF:
0.562
Gnomad OTH
AF:
0.515
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.472
AC:
71523
AN:
151662
Hom.:
18387
Cov.:
29
AF XY:
0.472
AC XY:
34937
AN XY:
74086
show subpopulations
African (AFR)
AF:
0.258
AC:
10677
AN:
41324
American (AMR)
AF:
0.587
AC:
8949
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.525
AC:
1820
AN:
3466
East Asian (EAS)
AF:
0.501
AC:
2572
AN:
5138
South Asian (SAS)
AF:
0.586
AC:
2805
AN:
4788
European-Finnish (FIN)
AF:
0.448
AC:
4694
AN:
10478
Middle Eastern (MID)
AF:
0.544
AC:
160
AN:
294
European-Non Finnish (NFE)
AF:
0.562
AC:
38182
AN:
67918
Other (OTH)
AF:
0.515
AC:
1084
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1751
3502
5253
7004
8755
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.496
Hom.:
2451
Bravo
AF:
0.473
Asia WGS
AF:
0.495
AC:
1721
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

MIR17HG-related disorder Benign:1
Oct 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.4
DANN
Benign
0.56
PhyloP100
-0.48

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7336610; hg19: chr13-92005137; API